<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>20</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Role of Muscle Relaxants – Spasmolytic (Thiocochlicoside) in Postoperative Pain Management after Mastectomy and Breast Reconstruction</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>743</FirstPage>
			<LastPage>749</LastPage>
			<ELocationID EIdType="pii">82577</ELocationID>
			
<ELocationID EIdType="doi">10.31557/APJCP.2019.20.3.743</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Maria </FirstName>
					<LastName>Bourazani</LastName>
<Affiliation>Department of Anesthesiology, Hellenic Anticancer Institute, Saint Savvas Hospital, Greece.</Affiliation>
<Identifier Source="ORCID">0000-0003-3921-6581</Identifier>

</Author>
<Author>
					<FirstName>Effie </FirstName>
					<LastName>Papageorgiou</LastName>
<Affiliation>Department
of Medical Laboratories, University of West Attikis, Greece.</Affiliation>

</Author>
<Author>
					<FirstName>Georgios </FirstName>
					<LastName>Zarkadas</LastName>
<Affiliation>Department of Plastic Surgery, Saint Savvas Hospital, Greece.</Affiliation>

</Author>
<Author>
					<FirstName>Theodora </FirstName>
					<LastName>Petrakopoulou</LastName>
<Affiliation>Department of Plastic Surgery, Saint Savvas Hospital, Greece.</Affiliation>

</Author>
<Author>
					<FirstName>Evridiki </FirstName>
					<LastName>Kaba</LastName>
<Affiliation>Department of Nursing, University of West Attikis, Greece.</Affiliation>

</Author>
<Author>
					<FirstName>Georgia </FirstName>
					<LastName>Fasoi</LastName>
<Affiliation>Department of Nursing, University of West Attikis, Greece.</Affiliation>

</Author>
<Author>
					<FirstName>Martha </FirstName>
					<LastName>Kelesi</LastName>
<Affiliation>Department of Nursing, Technological Educational
Institute of Athens, Athens, Greece.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>05</Month>
					<Day>22</Day>
				</PubDate>
			</History>
		<Abstract>Purpose: Post-operative pain after breast cancer surgery is a major problem and women undergoing mastectomy&lt;br /&gt;and breast reconstruction experience post-operative pain syndromes in approximately one-half of all cases. Patients&lt;br /&gt;who have undergone breast reconstruction after mastectomy can suffer from acute postoperative pain with moderate&lt;br /&gt;or strong tension. In some cases, chronic neuropathic pain syndromes may occur after surgery. Opioids are used to&lt;br /&gt;treat pain, with serious side effects. The systemic postoperative analgesic regimen as thiocochlicoside P.O. along&lt;br /&gt;with paracetamol and NSAIDs I.V., which may limit the administration of opioids without reducing pain relief,&lt;br /&gt;seems to be necessary. Materials and Methods: This study was a clinical trial randomizing 70 patients undergoing&lt;br /&gt;breast reconstruction. Two main protocols of systematic post-operative analgesia, one using thiocochlicoside (group&lt;br /&gt;A) and the other without them (group B), were used. Both groups received paracetamol X3 and lornoxicam X2 I.V.&lt;br /&gt;systematically. The pain measurement scale (NPS) used to measure post-operative pain. Likert scales were used to&lt;br /&gt;evaluate patient’s satisfaction and the difficulty from the side effects . An anonymous questionnaire was used for the&lt;br /&gt;data collection. Results: Statistically significant difference was found between pain on the day of surgery (p = 0.017)&lt;br /&gt;as well as the three subsequent days (p = 0.000). In group A , pain was reduced directly to half (Χ2 surgery pain =&lt;br /&gt;93.888, p = 0.000) especially on the first post-operative day. In group A the satisfaction with analgesic treatment was&lt;br /&gt;higher than in group B (p = 0.002). Conclusion: The use of thiocochlicoside in post-operative analgesia in breast&lt;br /&gt;reconstruction after mastectomy contributes to reduce the pain intensity experienced by patients and to reduce the side&lt;br /&gt;effects of opioid analgesics as a result of reduced demand for opioid analgesics. Patients who received the analgesia&lt;br /&gt;using muscle relaxants-spasmolytic reported greater satisfaction.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">breast reconstruction pain</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">analgesia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">muscle relaxants</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">spasmolytic</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">thiocochlicoside</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_82577_7f705934202af0b816b567fe58a76536.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
